BSE Live
Nov 11, 16:01Prev. Close
6692.20
Open Price
6669.25
Bid Price (Qty.)
6503.00 (10)
Offer Price (Qty.)
6534.10 (1)
NSE Live
Nov 11, 15:58Prev. Close
6691.50
Open Price
6711.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
6539.50 (330)
| Cash Flow of Divis Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,819.46 | 1,855.07 | 1,231.33 | 1,395.34 | 1,392.84 | |
| Net CashFlow From Operating Activities | 1,215.94 | 954.30 | 775.86 | 1,150.37 | 1,037.86 | |
| Net Cash Used In Investing Activities | -83.47 | -685.40 | -478.30 | -1,139.60 | -406.41 | |
| Net Cash Used From Financing Activities | -1,091.42 | -245.94 | -314.16 | 2.38 | -631.12 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 41.05 | 22.96 | -16.60 | 13.15 | 0.33 | |
| Cash And Cash Equivalents Begin of Year | 2.10 | -20.86 | -4.26 | -17.41 | 17.62 | |
| Cash And Cash Equivalents End Of Year | 43.15 | 2.10 | -20.86 | -4.26 | 17.95 |
11.11.2025
Accumulate Divis Laboratories; target of Rs 7050: Prabhudas Lilladher
10.11.2025
Sell Divis Laboratories; target of Rs 5400: ICICI Securities
10.09.2025
Reduce Divis Laboratories; target of Rs 5400: Geojit Financial Services
07.08.2025
Accumulate Divis Laboratories; target of Rs 6550: Prabhudas Lilladher
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill